ICU vs BIIB: Which Stock is Better?
Side-by-side comparison of Seastar Medical Holding Corp and Biogen Inc in 2026
ICU
Seastar Medical Holding Corp
$3.75
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | ICU | BIIB | Winner |
|---|---|---|---|
| Market Cap | $16.81M | $26.26B | BIIB |
| P/E Ratio | N/A | 20.38 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 5.3% | -0.1% | ICU |
| Gross Margin | 95.7% | 78.9% | ICU |
Analyze ICU
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ICU or BIIB a better investment?
Comparing ICU and BIIB: Seastar Medical Holding Corp has a market cap of $16.81M while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ICU and BIIB?
ICU (Seastar Medical Holding Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ICU or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ICU or BIIB?
ICU has higher revenue growth at 5.3% vs -0.1% for BIIB.
Which company is more profitable: ICU or BIIB?
Seastar Medical Holding Corp (ICU) has higher gross margins at 95.7% compared to 78.9% for BIIB.
Which is the larger company: ICU or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $16.81M for ICU.
Should I buy ICU or BIIB in 2026?
Both ICU and BIIB have investment merit. ICU trades at $3.75 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ICU and BIIB stock?
Key differences: Market Cap ($16.81M vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (5.3% vs -0.1%), Gross Margin (95.7% vs 78.9%).